No. 3 / 2026 Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and ...
Reference is made to TORM plc's (NASDAQ: TRMD) (NASDAQ: TRMD A) company announcement dated 5 March 2026. Please find enclosed formal notice of, and full details of the business to be proposed at, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results